A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors
Clinical trial NCT01963715 · TERMINATED
Trial details
- NCT number
- NCT01963715
- Sponsor
- ImmunoGen, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.